Showing 81-90 of 1679 results for "".
June Issue: Melanoma Updates - Epidemiology, Diagnostics, and Treatment
https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/In this article, we review the latest changes in melanoma incidence and mortality, highlight key disparities among minority populations, and summarize emerging trends in technology and treatment that are reshaping the future of melanoma care.DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide riRe-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaHIPAA Update
https://practicaldermatology.com/topics/practice-management/hipaa-update/19115/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute talks about recent changes to HIPAA and their possible implications for aesthetic medicine and cosmetic surgery practices. From Vegas Cosmetic Surgery.DERM2021: An Opportunity to Learn
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-opportunity-to-learn/19992/Suneel Chilukuri, MD shares what he got out of the DERM2021 NP/PA CME Conference—a chance to interact with attendees and presenters and learn from one another.Scientifically Speaking: New Directions in Acne Management, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-1/19939/The recognition that inflammation is at the heart of acne has led to changes in management approaches and better understanding of how treatments work. In the first of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD about acne approachesDermatology SEO for the New Year
https://practicaldermatology.com/topics/practice-management/newyearseo/18396/The rules of Search Engine Optimization (SEO) have changed dramatically, and even more changes are expected in the new year. Find out if your SEO strategy is outdated, and what you need to do about it in this Ekwa.com Marketing Educational video.MomGenes, Sernivo Approval, Industry Roundup
https://practicaldermatology.com/topics/psoriasis/dermwiretv-momgenes-sernivo-approval-industry-roundup/18613/In this edition of DermWireTV, from the editors of DermWire.com and Practical Dermatology® magazine, new research gives an up-close-and-personal view of how antiperspirant affects our microbiome. Galderma's new MomGenes campaign aims to change the way mothers and daughters talk about facial aging. TThe Evolution of Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anderson-2--apolesod/19038/Dina Anderson, MD, FAAD, discusses the changing landscape of injectable agents and how patients are more informed about various products and procedures.IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officia